Neuropathic Pain Second Indication Could Be Based On Single Trial – Cmte

A second neuropathic pain indication could be approved based on one additional trial, providing the single trial was well-controlled and produced robust results, FDA's Anesthetic and Life Support Drugs Advisory Committee said May 16